ClinicalTrials.gg
CompletedNCT07042646Updated Jun 29, 2025

Sexual Function and Quality of Sexual Life in Women With Physical Disabilities

An interventional study of Sexual and Reproductive Health Training program in Disability Physical, sponsored by Amasya University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-29.

Sponsored by Amasya University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Sep 2024, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

This pilot randomized controlled trial will be carried out with women with physical disabilities registered at a disability center. A total of 49 participants will be randomly assigned to either the intervention group or the control group. Following a three-week follow-up period, the study will be completed, with a total of 26 participants: 16 in the intervention group and 10 in the control group . SRH training will be provided to the intervention group once a week, for a total of three sessions. At the beginning and end of the study, both groups will be administered a survey including demographic information, the Sexual Quality of Life Questionnaire-Female (SQLQ-F), and the Female Sexual Function Index (FSFI).

Read the detailed description

Background: Ensuring that women with disabilities, who are among disadvantaged groups, maintain and improve their sexual and reproductive health (SRH) on equal terms with other women is of great importance. The purpose of this study is to examine the impact of SRH training provided to women with physical disabilities on their sexual function and quality of sexual life, as well as to assess the feasibility and acceptability of the educational intervention.

Method: This pilot randomized controlled trial will be carried out with women with physical disabilities registered at a disability center. A total of 49 participants will be randomly assigned to either the intervention group or the control group. Following a three-week follow-up period, the study will be completed, with a total of 26 participants: 16 in the intervention group and 10 in the control group . SRH training will be provided to the intervention group once a week, for a total of three sessions. At the beginning and end of the study, both groups will be administered a survey including demographic information, the Sexual Quality of Life Questionnaire-Female (SQLQ-F), and the Female Sexual Function Index (FSFI).

02

Conditions studied

  • Disability Physical

Keywords

  • women with physically disabled
  • sexual health
  • psychosexual dysfunctions
  • sexuality
03

In context

Sexual Dysfunctions, Psychological

138 studies on the registry are indexed under Sexual Dysfunctions, Psychological; 10 are open to participants now.

This study's enrollment of 26 is below the median of 100 across 114 interventional studies indexed under Sexual Dysfunctions, Psychological.

Browse Sexual Dysfunctions, Psychological studies →

Lead sponsor

Amasya University is the lead sponsor of 81 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Those who were female between the ages of 18-65, physically disabled, married, did not have a mental health problem, did not have a communication barrier, and volunteered were included in this study.

Exclusion criteria

Exclusion Criteria:

  • being a man
  • having a disability other than physical disability
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Intervention group

    Sexual and Reproductive Health Training program received the intervention group.

    Behavioral: Sexual and Reproductive Health Training program

  • No intervention
    Control group

    no intervention was the control group.

Interventions

  • BehavioralSexual and Reproductive Health Training program

    'The Sexual and Reproductive Health education program was prepared by researchers who are experts in the field of public health and public health nursing. The program was implemented once a week for 3 weeks (why 3 weeks) in 50-60 minute sessions (Table 1). The content and duration of the application were prepared in accordance with the Ministry of Health Sexual and Reproductive Health: National Strategic Action Plan for the Health Sector (2005-2015) and the Turkey Reproductive Health Program Sexual and Reproductive Health Service Standards (2007). Each program session was two education sessions, and all the questions of the disabled woman were answered .

06

What researchers measure

Primary outcomes

  1. Quality of Sexual Life

    The scale has 6 sub-dimensions: desire, arousal, lubrication, orgasm, satisfaction, and pain (Rosen et al., 2000). Each item is scored from 0 to 5. The highest score that can be obtained from the scale is 95.0, and the lowest score is 4.0.

    Time frame: 1 months

Secondary outcomes

  1. Sexual Function

    The scale is suitable for women aged 18 and over, is a six-point Likert type, and consists of 18 items. Each item is answered by considering the sexual life in the last four weeks. The original version of the scale states that each item can be scored between 1-6 or 0-5. In this study, a 1-6 point system was used (1=I completely agree, 2=I largely agree, 3=I partially agree, 4=I partially disagree, 5=I largely disagree, 6=I completely disagree). The highest score that can be obtained from the scale in the 1-6 point system is 108, and the lowest score is 18.

    Time frame: 1 months

07

Study locations

1 site
  • Amasya University Faculty of Health Sciences
    Amasya, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07042646
Lead sponsor
Amasya University
Responsible party
Gozde Yıldız Daş Geçim (Assist. Prof., Amasya University) — Principal investigator
First posted
Jun 29, 2025
Start date
Sep 14, 2024
Primary completion
Oct 14, 2024
Completion
Mar 20, 2025
Last update
Jun 29, 2025

Study contacts

zehra incedal sonkaya, PhD
study chair · Amasya University
murat yücel, PhD
study chair · Amasya University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion